A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
X-ray Crystallography Core Facility Bookmark and Share

X-ray Crystallography Core Facility

The X-ray Crystallography Core Facility is one of the Shared Resources facilities at Beckman Research Institute of City of Hope.
 
The objective of the facility is to:
 
  1. Provide structural information to understand mechanisms of biological systems at the atomic level;
  2. Validate binding sites of lead compounds of therapeutic interest;
  3. Facilitate lead discovery through co-crystallization of therapeutic targets and small molecule libraries.
     
Services provided include:
 
  • Sample analysis
  • Crystallization
  • Diffraction quality
  • Data collections
  • Structure determination
 
Contact Us:
 
John C. Williams, Ph.D., Director
Phone:  626-256-HOPE (4673), ext. 60227
City of Hope
1500 East Duarte Road
Duarte, CA  91010-3000
Flower Building, Room 148
 
Research reported in this publication included work performed in the X-ray Crystallography Core supported by the National Cancer Institute of the National Institutes of Health under award number P30CA33572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Services

The X-ray crystallography Core provides a state-of-the-art facility for the generation of crystals and structure determination of macromolecules including proteins, DNA, RNA, and complexes between macromolecules and their ligands.
 
Sample Analysis:
 
Consultation andin silicoanalysis
  • Protein expression and purification
  • Domain structure, including disorder and secondary structure prediction
 
Physical Analysis
 
  • Native PAGE using GE HealthSciences PhastGel
  • Limited Proteolysis and characterization by SDS-PAGE
  • Size Exclusion Chromatography
  • Sedimentation Equilibrium analysis by AUC
  • Sedimentation Velocity analysis by AUC.
 
Crystallization:
 
  1. Set up crystallization trials at 4 ºC and/or 20 ºC.
    a.Initial trials (e.g., appropriate concentrations)
    b.Full scale trials (4 different 96 well factorialsat 3 protein concentrations and 2 temperatures)
     
  2. Optimization – additive screens and factorial overlays
     
  3. Automated Screening at 2 temperatures (scan daily forfirst week, weekly thereafter, finish experiment at 3 months)
 
Diffraction quality:
 
  1. Test diffraction using capillary mounted crystal
     
  2. Test/screen cryo-conditions
 
Data collection:
 
  1. Collect, reduce and merge data. Generate table of statistics
  2. MAD/SAD phasing – help design, collect, reduce and merge MAD data
  3. Generate table of statistics including anomalous dispersion differences
 
Structure Determination:
 
  1. Solve structure by Molecular Replacement
  2. Solve structure by MAD/SAD phasing
  3. Refine structure
  4. Produce relevant statistics (e.g., R and Rfree, RMS deviations)
  5. Structural analysis (superpositions, electrostatics, etc)
  6. Deposit Structure at PDB
 

Equipment

The facility houses a Mosquito Crystallization Robot, a Formulatrix imaging robot (with Automated Crystal Screening at 4 ºC and 20 ºC), a Rigaku Micromax 007 with an R-AxisIV++, and an Oxford cryojet and relevant software and computational hardware for structure determination.
 
The facility also houses a Beckman XLI analytical ultracentrifuge and a GE Health Phast Gel system for the characterization of macromolecular properties.
 
Mosquito Crystallization Robot
The mosquito crystallization robot permits hanging drop, sitting drop, and batch methods in a 96 well format using minimal amounts of protein (~16mL/trail). A number of commercial crystallization screens are available (Qiagen, Hampton Research, Jena).
   
Formulatrix Automated Visualization of Crystallization Trials
The core houses two Formulatrix imaging robots for visualization at 4 ºC and 20 ºC.
Users can quickly browse images, score potential hits and follow crystal growth in time.
   
Rigaku X-ray Diffractometer
Micromax 007 HF, R-axis V++, and Oxford cryojets allow full structure determination.
   
Beckman XL-I Proteomelab
The Beckman Analytical ultracentrifuge affords accurate measurement of hydrodynamic properties, including the association constant of macromolecular complexes, as well as small molecule-macromolecular interactions
 
 

Abstract for Grants

The X-ray core atBeckman Research Institute of City of Hope is a state-of-the-art crystallization and X-ray facility. This facility houses a Mosquito Crystallization robot that uses 50 to 100 nL volumes and permits three different crystallization formats; hanging drop, sitting drops or batch methods under oil. The facility has multiple commercial crystallization factorials (e.g., Hampton, Jena, Nextal), that are frequently used, such that they are always fresh. It has also developed protocols for rapid optimization of individual conditions.
 
To follow crystallization trials, two Formulatrix Imaging Robots are used that automatically image each drop, according to a preset schedule (e.g., nightly). This allows follow-up of crystallization trends at two temperatures and produces a visual record for analysis.
 
For diffraction studies, a Rigaku 007HF generator with an R-axis IV++ imager has been purchased. An Oxford cryojet permits data collection at 100 K to reduce radiation damage.
 
The facility has all the software and computational hardware necessary to determine structures of macromolecular complexes.
 

Pricing

Prices and availability vary. Please contact us for current information.
 
If you are a City of Hope employee, please visit the new intranet site for pricing.

 

 

X-ray Crystallography Core Facility

X-ray Crystallography Core Facility

The X-ray Crystallography Core Facility is one of the Shared Resources facilities at Beckman Research Institute of City of Hope.
 
The objective of the facility is to:
 
  1. Provide structural information to understand mechanisms of biological systems at the atomic level;
  2. Validate binding sites of lead compounds of therapeutic interest;
  3. Facilitate lead discovery through co-crystallization of therapeutic targets and small molecule libraries.
     
Services provided include:
 
  • Sample analysis
  • Crystallization
  • Diffraction quality
  • Data collections
  • Structure determination
 
Contact Us:
 
John C. Williams, Ph.D., Director
Phone:  626-256-HOPE (4673), ext. 60227
City of Hope
1500 East Duarte Road
Duarte, CA  91010-3000
Flower Building, Room 148
 
Research reported in this publication included work performed in the X-ray Crystallography Core supported by the National Cancer Institute of the National Institutes of Health under award number P30CA33572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Services

Services

The X-ray crystallography Core provides a state-of-the-art facility for the generation of crystals and structure determination of macromolecules including proteins, DNA, RNA, and complexes between macromolecules and their ligands.
 
Sample Analysis:
 
Consultation andin silicoanalysis
  • Protein expression and purification
  • Domain structure, including disorder and secondary structure prediction
 
Physical Analysis
 
  • Native PAGE using GE HealthSciences PhastGel
  • Limited Proteolysis and characterization by SDS-PAGE
  • Size Exclusion Chromatography
  • Sedimentation Equilibrium analysis by AUC
  • Sedimentation Velocity analysis by AUC.
 
Crystallization:
 
  1. Set up crystallization trials at 4 ºC and/or 20 ºC.
    a.Initial trials (e.g., appropriate concentrations)
    b.Full scale trials (4 different 96 well factorialsat 3 protein concentrations and 2 temperatures)
     
  2. Optimization – additive screens and factorial overlays
     
  3. Automated Screening at 2 temperatures (scan daily forfirst week, weekly thereafter, finish experiment at 3 months)
 
Diffraction quality:
 
  1. Test diffraction using capillary mounted crystal
     
  2. Test/screen cryo-conditions
 
Data collection:
 
  1. Collect, reduce and merge data. Generate table of statistics
  2. MAD/SAD phasing – help design, collect, reduce and merge MAD data
  3. Generate table of statistics including anomalous dispersion differences
 
Structure Determination:
 
  1. Solve structure by Molecular Replacement
  2. Solve structure by MAD/SAD phasing
  3. Refine structure
  4. Produce relevant statistics (e.g., R and Rfree, RMS deviations)
  5. Structural analysis (superpositions, electrostatics, etc)
  6. Deposit Structure at PDB
 

Equipment

Equipment

The facility houses a Mosquito Crystallization Robot, a Formulatrix imaging robot (with Automated Crystal Screening at 4 ºC and 20 ºC), a Rigaku Micromax 007 with an R-AxisIV++, and an Oxford cryojet and relevant software and computational hardware for structure determination.
 
The facility also houses a Beckman XLI analytical ultracentrifuge and a GE Health Phast Gel system for the characterization of macromolecular properties.
 
Mosquito Crystallization Robot
The mosquito crystallization robot permits hanging drop, sitting drop, and batch methods in a 96 well format using minimal amounts of protein (~16mL/trail). A number of commercial crystallization screens are available (Qiagen, Hampton Research, Jena).
   
Formulatrix Automated Visualization of Crystallization Trials
The core houses two Formulatrix imaging robots for visualization at 4 ºC and 20 ºC.
Users can quickly browse images, score potential hits and follow crystal growth in time.
   
Rigaku X-ray Diffractometer
Micromax 007 HF, R-axis V++, and Oxford cryojets allow full structure determination.
   
Beckman XL-I Proteomelab
The Beckman Analytical ultracentrifuge affords accurate measurement of hydrodynamic properties, including the association constant of macromolecular complexes, as well as small molecule-macromolecular interactions
 
 

Abstract for Grants

Abstract for Grants

The X-ray core atBeckman Research Institute of City of Hope is a state-of-the-art crystallization and X-ray facility. This facility houses a Mosquito Crystallization robot that uses 50 to 100 nL volumes and permits three different crystallization formats; hanging drop, sitting drops or batch methods under oil. The facility has multiple commercial crystallization factorials (e.g., Hampton, Jena, Nextal), that are frequently used, such that they are always fresh. It has also developed protocols for rapid optimization of individual conditions.
 
To follow crystallization trials, two Formulatrix Imaging Robots are used that automatically image each drop, according to a preset schedule (e.g., nightly). This allows follow-up of crystallization trends at two temperatures and produces a visual record for analysis.
 
For diffraction studies, a Rigaku 007HF generator with an R-axis IV++ imager has been purchased. An Oxford cryojet permits data collection at 100 K to reduce radiation damage.
 
The facility has all the software and computational hardware necessary to determine structures of macromolecular complexes.
 

Pricing

Pricing

Prices and availability vary. Please contact us for current information.
 
If you are a City of Hope employee, please visit the new intranet site for pricing.

 

 
Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Recognized nationwide for its innovative biomedical research, City of Hope's Beckman Research Institute is home to some of the most tenacious and creative minds in science.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 
Media Inquiries/Social Media

For media inquiries contact:

Dominique Grignetti
800-888-5323
dgrignetti@coh.org

 

For sponsorships inquiries please contact:

Stefanie Sprester
213-241-7160
ssprester@coh.org

Christine Nassr
213-241-7112
cnassr@coh.org

 
CONNECT WITH US
Facebook  Twitter  YouTube  Blog
 
NEWS & UPDATES
  • September is Prostate Cancer Awareness Month. Here, Bertram Yuh, M.D., assistant clinical professor in the Division of Urology and Urologic Services at City of Hope, explains the importance of understanding the risk factors for the disease and ways to reduce those risks, as well as overall prostate health. “Wha...
  • ** Learn more about prostate health, plus prostate cancer research and treatment, at City of Hope. ** Learn more about getting a second opinion at City of Hope by visiting us online or by calling 800-826-HOPE (4673). City of Hope staff will explain what’s required for a consult at City of Hope and help yo...
  • Childhood cancer survival rates have increased dramatically over the past 40 years. More than 80 percent of children with cancer now survive five years or more, which is a tremendous feat. Despite the survival rate increase, cancer continues to be the No. 1 disease killer and second-leading cause of death in ch...
  • Although a stem cell transplant can be a lifesaving procedure for people diagnosed with a blood cancer or blood disorder, the standard transplant may not be appropriate for all patients. This is because the conditioning regimen (the intensive chemotherapy and/or radiation treatments preceding the transplant) is...
  • Brain tumor removal would seem to be the obvious course of action in the wake of a brain tumor diagnosis, but that’s not always the case. Some tumors are too difficult for many surgeons to reach or too close to areas that control vital functions. Removing them just proves too risky. A new device being con...
  • Hijacking the same sorts of viruses that cause HIV and using them to reprogram immune cells to fight cancer sounds like stuff of the future. Some scientists believe that the future is closer than we think – and are now studying the approach in clinical trials at City of Hope. Immunotherapy is a promising approa...
  • Jennifer Linehan, M.D., an assistant clinical professor in City of Hope’s Division of Urology and Urologic Oncology in Antelope Valley, thought she knew all there was to know about treating prostate cancer. Then her father was diagnosed with the disease. This is her story. ** My father is 69 years old, has no h...
  • Nausea is the one of the most well-known, and dreaded, side effects of cancer treatment — and with good reason. Beyond the quality-of-life issues that it causes, severe nausea can prevent patients from receiving enough nutrients and calories at a time when they need every edge they can get. A few simple actions...
  • With Labor Day just around the corner, summer is on its way out. But just because summertime is ending doesn’t mean we can skip sunscreen. Protection from ultraviolet (UV) radiation is needed all year round. Exposure to UV radiation — whether from the sun or from artificial sources such as sunlamps used i...
  • Undergoing reconstructive surgery may seem like a forgone conclusion for survivors of breast cancer, but that doesn’t appear to be the case. A new study has found that most breast cancer survivors who undergo a mastectomy decide against surgical reconstruction of their breasts. The reasons for such a deci...
  • Nearly four decades ago, City of Hope began its bone marrow transplant program. Its first transplant reunion celebration was a single patient and his donor, also his brother. This year, City of Hope welcomed hundreds of hematopoietic cell transplant (HCT) recipients to the annual bone marrow transplant/HCT reun...
  • The burgeoning type 2 diabetes epidemic casts a pall over the health of America’s public. New research now shows the looming threat is getting worse. Much worse. A diabetes trends study published earlier this month in the Lancet Diabetes and Endocrinology by researchers at the federal Centers for Disease Contro...
  • An aspirin a day might help keep breast cancer away for some breast cancer survivors, a new study suggests. Obese women who have had breast cancer could cut their risk of a recurrence in half if they regularly take aspirin or other nonsteroidal anti-inflammatory drugs, called NSAIDs, report researchers from the...
  • Christine Crews isn’t only a fitness enthusiast, she’s also a personal trainer and fitness instructor. Being active defines her life. So when she was diagnosed with bladder cancer at age 30, she decided she absolutely couldn’t let the disease interfere with that lifestyle. And it didn’t. For t...
  • Cancer treatment and the cancer itself can cause changes in your sense of taste or smell. These side effects typically subside after treatment ends, but there are ways to help alleviate those bitter and metallic tastes in your mouth. Here are tips from the National Cancer Institute to help keeps tastes and food...